Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Jackson-Spence

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Urologic Oncology|July 18, 2024
Biomarkers associated with survival in patients with platinum-refractory urothelial carcinoma treated with paclitaxelFrancesca Jackson-Spence, Charlotte Ackerman, Robert Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal CancerFrancesca Jackson-Spence, James Larkin, Poulam Patel, et al.
European Urology Oncology|November 3, 2022
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumChun Loo Gan, Jiaming Huang, Elizabeth Pan, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Urologic Oncology|July 18, 2024
Biomarkers associated with survival in patients with platinum-refractory urothelial carcinoma treated with paclitaxelFrancesca Jackson-Spence, Charlotte Ackerman, Robert Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal CancerFrancesca Jackson-Spence, James Larkin, Poulam Patel, et al.
European Urology Oncology|November 3, 2022
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumChun Loo Gan, Jiaming Huang, Elizabeth Pan, et al.
Pageof 3